Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Yestar Healthcare Holdings Co Days Payable?
Yestar Healthcare Holdings CoHKSE:02393 +4.55% Days Payable is 67.86 as of Jun. 2026, which is 4% above its 10-year median of 65.09. The stock has 4 warning signs investors should review. Among 797 Medical Devices & Instruments companies, Yestar Healthcare Holdings Co ranks worse than 53.32% on this metric.
The historical rank and industry rank for Yestar Healthcare Holdings Co's Days Payable or its related term are showing as below:
HKSE:02393'
s Days Payable Range Over the Past 10 Years
Min: 53.55 Med: 65.09 Max: 105.19
Current: 65.11
During the past 13 years, Yestar Healthcare Holdings Co's highest Days Payable was 105.19. The lowest was 53.55. And the median was 65.09.
HKSE:02393's Days Payable is ranked worse than 53.32% of 797
companies
in the Medical Devices & Instruments industry
Industry Median: 69.48
vs HKSE:02393: 65.11
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02393 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Yestar Healthcare Holdings Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yestar Healthcare Holdings Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Yestar Healthcare Holdings Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Yestar Healthcare Holdings Co's Days Payable falls into.
Yestar Healthcare Holdings Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yestar Healthcare Holdings Co (HKSE:02393) has a Days Payable of 67.86 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Yestar Healthcare Holdings Co and its competitors. This is near median its historical median of 65.09. Over the past decade, Yestar Healthcare Holdings Co's Days Payable has ranged from 53.55 to 105.19. According to the industry distribution chart, Yestar Healthcare Holdings Co ranks #425 out of 797 companies in the Medical Devices & Instruments industry, placing it in the top 53.3%.
Is Yestar Healthcare Holdings Co's Days Payable too high?
Yestar Healthcare Holdings Co's current Days Payable of 67.86 is near median its 10-year median of 65.09. Over the past 10 years, this metric has ranged from a low of 53.55 to a high of 105.19. The Medical Devices & Instruments industry median Days Payable is 69.48. Yestar Healthcare Holdings Co's value of 67.86 is 2.3% below this industry median. Based on the distribution chart, Yestar Healthcare Holdings Co ranks #425 out of 797 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does Yestar Healthcare Holdings Co's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Yestar Healthcare Holdings Co ranks #425 out of 797 companies for Days Payable. This places Yestar Healthcare Holdings Co in the lower half of its industry. The industry median Days Payable is 69.48. Yestar Healthcare Holdings Co's value of 67.86 is 2.3% below this benchmark. Historically, Yestar Healthcare Holdings Co's own Days Payable has ranged from 53.55 to 105.19 over the past decade. While the company's 10-year median is 65.09 vs. the industry median of 69.48, Yestar Healthcare Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 69.48, based on 797 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yestar Healthcare Holdings Co's current Days Payable of 67.86 is 2.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Yestar Healthcare Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 69.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yestar Healthcare Holdings Co's current Days Payable is 67.86, which is near median its own 10-year median of 65.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yestar Healthcare Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Yestar Healthcare Holdings Co (HKSE:02393) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.05, compared to a current price of HK$0.07 — trading 38% above its estimated fair value. The current Days Payable is 67.86, which is near median its 10-year median of 65.09 and 2.3% below the Medical Devices & Instruments industry median of 69.48. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Yestar Healthcare Holdings Co (HKSE:02393), the current Days Payable is 67.86 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Yestar Healthcare Holdings Co Ltd is engaged in the manufacture, distribution, and sale of medical imaging products, distribution of In Vitro Diagnostic (IVD) products, and manufacture and sale of dental films. The Group has two reportable operating segments: Imaging printing products segment, which includes the manufacture and sale of colour photographic paper, industrial NDT x-ray films and PWB films, and trading of imaging equipment; and Medical products and equipment segment, which generates maximum revenue and includes manufacture and sale of medical dry films, medical wet films and dental films, and sale of medical equipment and diagnostic reagents. The Group operates its business in Mainland China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02393 has been successfully added to your 
